-
Je něco špatně v tomto záznamu ?
The incidence and results of laser enhancement after cataract and refractive surgery with trifocal lens implantation
D. Barakova, D. Jordanovova, M. Sramka, A. Kaluzakova, M. Sajdikova
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
33542541
DOI
10.5507/bp.2021.010
Knihovny.cz E-zdroje
- MeSH
- fakoemulzifikace * MeSH
- implantace nitrooční čočky metody MeSH
- incidence MeSH
- lasery MeSH
- lidé MeSH
- protézy - design MeSH
- refrakční vady * MeSH
- retrospektivní studie MeSH
- spokojenost pacientů MeSH
- zkalení zadního pouzdra čočky * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
PURPOSE: To evaluate the incidence of laser enhancement following cataract surgery and refractive lens exchange (RLE) with FineVision Micro F trifocal lens implantation (PhysIOL, Liège, Belgium). METHODS: Retrospective study of patients who had undergone cataract or RLE surgery and had received a FineVision Micro F intraocular lens. Laser enhancement of residual refractive error was determined. Visual acuity (VA) assessments were performed before and after surgery: uncorrected distance VA (UCDVA), best-corrected distance VA (BCDVA), uncorrected near VA (UCNVA), plus preoperative and postoperative spherical equivalent (SE) assessments. RESULTS: Of the 1129 eyes from 596 patients, 61 (5.4%) required laser enhancement to correct residual refractive error (by group: 30/679 eyes [4.4%] cataract; 31/450 eyes [6.9%] RLE). Eleven eyes received FemtoLASIK; 50 eyes received PRK. Mean UCDVA before laser enhancement was 0.26±0.19 logMAR and 0.24±0.14 in the FemtoLASIK and PRK groups, respectively. After laser enhancement, these were 0.04±0.05 logMAR and 0.13±0.19, respectively; BCDVA values were 0.00±0.00 logMAR in the FemtoLASIK group and 0.06±0.11 in the PRK group. Laser enhancement improved UCNVA (Jaeger) from 2-3 to 1-2 in both groups. Enhancement reduced preoperative SE of -0.39±0.99 D and -0.53±0.58 D (FemtoLASIK and PRK groups, respectively) to 0.24±0.36 D and 0.04±0.47 D. CONCLUSIONS: The FineVision Micro F trifocal lens is an effective solution for gaining increased spectacle independence. The incidence of residual refractive error requiring laser enhancement is low, and laser procedures are a safe and effective solution for improving the quality of vision and patient satisfaction. SYNOPSIS: Laser enhancement rates and outcomes were determined following cataract / refractive lens exchange surgery that used a trifocal IOL. Enhancement was safe and effective and rates were low (5.4%).
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22014557
- 003
- CZ-PrNML
- 005
- 20230308115401.0
- 007
- ta
- 008
- 220602s2022 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2021.010 $2 doi
- 035 __
- $a (PubMed)33542541
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Baráková, Drahomíra, $u Gemini Eye Clinic, Prague, Czech Republic $u Department of Ophthalmology, Motol University Hospital, Prague, Czech Republic $d 1955- $7 xx0000259
- 245 14
- $a The incidence and results of laser enhancement after cataract and refractive surgery with trifocal lens implantation / $c D. Barakova, D. Jordanovova, M. Sramka, A. Kaluzakova, M. Sajdikova
- 520 9_
- $a PURPOSE: To evaluate the incidence of laser enhancement following cataract surgery and refractive lens exchange (RLE) with FineVision Micro F trifocal lens implantation (PhysIOL, Liège, Belgium). METHODS: Retrospective study of patients who had undergone cataract or RLE surgery and had received a FineVision Micro F intraocular lens. Laser enhancement of residual refractive error was determined. Visual acuity (VA) assessments were performed before and after surgery: uncorrected distance VA (UCDVA), best-corrected distance VA (BCDVA), uncorrected near VA (UCNVA), plus preoperative and postoperative spherical equivalent (SE) assessments. RESULTS: Of the 1129 eyes from 596 patients, 61 (5.4%) required laser enhancement to correct residual refractive error (by group: 30/679 eyes [4.4%] cataract; 31/450 eyes [6.9%] RLE). Eleven eyes received FemtoLASIK; 50 eyes received PRK. Mean UCDVA before laser enhancement was 0.26±0.19 logMAR and 0.24±0.14 in the FemtoLASIK and PRK groups, respectively. After laser enhancement, these were 0.04±0.05 logMAR and 0.13±0.19, respectively; BCDVA values were 0.00±0.00 logMAR in the FemtoLASIK group and 0.06±0.11 in the PRK group. Laser enhancement improved UCNVA (Jaeger) from 2-3 to 1-2 in both groups. Enhancement reduced preoperative SE of -0.39±0.99 D and -0.53±0.58 D (FemtoLASIK and PRK groups, respectively) to 0.24±0.36 D and 0.04±0.47 D. CONCLUSIONS: The FineVision Micro F trifocal lens is an effective solution for gaining increased spectacle independence. The incidence of residual refractive error requiring laser enhancement is low, and laser procedures are a safe and effective solution for improving the quality of vision and patient satisfaction. SYNOPSIS: Laser enhancement rates and outcomes were determined following cataract / refractive lens exchange surgery that used a trifocal IOL. Enhancement was safe and effective and rates were low (5.4%).
- 650 12
- $a zkalení zadního pouzdra čočky $7 D058442
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a lasery $7 D007834
- 650 _2
- $a implantace nitrooční čočky $x metody $7 D019654
- 650 _2
- $a spokojenost pacientů $7 D017060
- 650 12
- $a fakoemulzifikace $7 D018918
- 650 _2
- $a protézy - design $7 D011474
- 650 12
- $a refrakční vady $7 D012030
- 650 _2
- $a retrospektivní studie $7 D012189
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Jordánová, Dagmar $u Gemini Eye Clinic, Prague, Czech Republic $7 xx0269205
- 700 1_
- $a Sramka, Martin $u Gemini Eye Clinic, Prague, Czech Republic $u Department of Circuit theory/Faculty of Electrical engineering, Czech Technical University in Prague, Czech Republic
- 700 1_
- $a Kaluzakova, Adriana $u Gemini Eye Clinic, Prague, Czech Republic
- 700 1_
- $a Sajdikova, Martina $u Gemini Eye Clinic, Prague, Czech Republic
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $x 1213-8118 $g Roč. 166, č. 2 (2022), s. 222-227
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33542541 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y p $z 0
- 990 __
- $a 20220602 $b ABA008
- 991 __
- $a 20230308115356 $b ABA008
- 999 __
- $a ok $b bmc $g 1824812 $s 1165778
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 166 $c 2 $d 222-227 $e 20210204 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK198 $a Pubmed-20220602